Status:
COMPLETED
Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
Lead Sponsor:
Somerset Pharmaceuticals
Conditions:
Major Depression
Eligibility:
All Genders
65+ years
Phase:
PHASE3
Brief Summary
Objective of this 16-week, open-label study is to assess the safety and tolerability of once daily application of three doses of STS during continuous dosing in the treatment of elderly subjects with ...
Eligibility Criteria
Inclusion
- Men/Women in good health 65 years or older
- Ability to read, understand and sign study informed consent
- Major depression- mild to severe based on rating scale
Exclusion
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00285766
Start Date
August 1 2002
End Date
July 1 2005
Last Update
April 22 2008
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohammed Bari, M.D.
Chula Vista, California, United States, 91910
2
Charles Meredith, M.D.
San Diego, California, United States, 92108
3
Daniel Zimbroff, M.D.
Upland, California, United States, 94589
4
Kathleen Toups, M.D.
Walnut Creek, California, United States, 94589